BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Chinese Patent Office
Federal Trade Commission
Cantor Fitzgerald
Deloitte
Boehringer Ingelheim
Dow
Daiichi Sankyo
Harvard Business School
Accenture

Generated: January 22, 2018

DrugPatentWatch Database Preview

Claims for Patent: 7,696,326

« Back to Dashboard

Summary for Patent: 7,696,326
Title:Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
Abstract: The invention of the present application relates to a method for obtaining antibodies directed against a carbohydrate moiety contained in a carbohydrate peptide conjugate, by administering to a subject a composition containing a carbohydrate peptide conjugate and collecting the antibodies directed against the said carbohydrate moiety from a serum previously obtained from the subject.
Inventor(s): Bay; Sylvie (Paris, FR), Cantacuzene; Daniele (Paris, FR), Leclerc; Claude (Paris, FR), Lo-Man; Richard (Paris, FR)
Assignee: Institut Pasteur (Paris, FR)
Application Number:11/619,457
Patent Claims: 1. A method for obtaining antibodies directed against a carbohydrate moiety (B) contained in a carbohydrate peptide conjugate, comprising: a) administering to a human or an animal body a composition comprising a carbohydrate peptide conjugate having a carbohydrate content ranging from 33% (w/w) to 90% (w/w), said conjugate being selected from the group of conjugates of formulae (a) to (f) below: ##STR00002## wherein: K is a lysyl residue, T is a CD4.sup.+ T cell epitope, and B and Tn is a Tn antigen selected from the group consisting of .alpha.-Gal-Nac-Ser, .alpha.-Gal-Nac-Thr, .beta.-Gal-( 1-3)-.alpha.-Gal-Nac-Ser, .beta.-Gal(1-3).alpha.-Gal-Nac-Thr(.alpha.-Gal-Nac-Ser/Thr).sub.2, (.alpha.-Gal-Nac-Ser/Thr).sub.3 and (.alpha.-Gal-Nac-Ser/Thr).sub.6; and b) collecting the antibodies directed against the said carbohydrate moiety (B) from a serum obtained from said human or animal body.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Argus Health
Baxter
Colorcon
Merck
Deloitte
US Army
AstraZeneca
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot